APA (7th ed.) Citation

Zhu, E., Yuriditsky, E., Raco, V., Katz, A., Papadopoulos, J., Horowitz, J., . . . Ahuja, T. (2024). Anti‐factor Xa as the preferred assay to monitor heparin for the treatment of pulmonary embolism. International Journal of Laboratory Hematology, 46(2), 354. https://doi.org/10.1111/ijlh.14207

Chicago Style (17th ed.) Citation

Zhu, Eric, Eugene Yuriditsky, Veronica Raco, Alyson Katz, John Papadopoulos, James Horowitz, Thomas Maldonado, and Tania Ahuja. "Anti‐factor Xa as the Preferred Assay to Monitor Heparin for the Treatment of Pulmonary Embolism." International Journal of Laboratory Hematology 46, no. 2 (2024): 354. https://doi.org/10.1111/ijlh.14207.

MLA (9th ed.) Citation

Zhu, Eric, et al. "Anti‐factor Xa as the Preferred Assay to Monitor Heparin for the Treatment of Pulmonary Embolism." International Journal of Laboratory Hematology, vol. 46, no. 2, 2024, p. 354, https://doi.org/10.1111/ijlh.14207.